Posted by admin

In 2025, a drug invented by AI made cancer start disappearing inside a human for the first time in history. The patient had run out of options after four failed rounds of traditional treatment. Then a medicine designed by AI in under twelve months pushed her tumor back, and it stayed back. Over a hundred more AI-made drugs are in human trials right now. And the most powerful weapon AI has against cancer isn't a drug at all. This is the story of how the fight against cancer stopped being a purely human effort. Every claim in this video comes from published research and public reporting: The Lancet, Nature, the Journal of Cell Biology, the Journal of Clinical Oncology, the WHO's cancer agency, Cornell University, and official trial results from Recursion, GRAIL, Merck and Moderna. None of this is a forecast. The trials happened, the patients are real, and the tools are reaching hospitals now. TIMESTAMPS: 00:00 - Intro 00:35 - How It All Started 02:34 - There Is No Such Thing As Cancer 04:16 - The Pattern That Changed Everything 04:56 - How AI Is Helping Doctors 06:08 - This AI Detects Cancer 6 Years Earlier 07:27 - The Cancer OFF Switch 10:25 - AI Can Make Specific Medicine 11:07 - 100+ Patients Are Already Taking The Meds 11:53 - The Dark Side 13:54 - Can AI Cure Cancer? 14:40 - How Will The Future Look Like? 16:07 - Outro Discover 50,000+ AI tools at: https://theresanaiforthat.com RESOURCES & FURTHER READING: THE FIRST AI-DESIGNED CANCER DRUG: - "Recursion Reports Interim Phase 1 Clinical Data for REC-617 Monotherapy" | Recursion / GlobeNewswire | December 9, 2024 | https://www.globenewswire.com/news-release/2024/12/09/2994128/0/en/Recursion-Reports-Interim-Phase-1-Clinical-Data-for-REC-617-Monotherapy-a-Potential-Best-in-Class-CDK7-Inhibitor-With-Encouraging-Patient-Response-and-Favorable-Tolerability.html - "AI-Discovered Drugs in Clinical Trials 2026: Full Pipeline" | IntuitionLabs | July 31, 2026 | https://intuitionlabs.ai/articles/ai-discovered-drugs-clinical-trials-2026 - "Isomorphic Labs raises $600m from Thrive Capital" | Sifted | March 31, 2025 | https://sifted.eu/articles/isomorphic-labs-600m-raise-thrive-capital-news AI CANCER SCREENING: - "AI-supported mammography screening results in fewer aggressive and advanced breast cancers" | Lund University / ecancer | January 30, 2026 | https://ecancer.org/en/news/27721-ai-supported-mammography-screening-results-in-fewer-aggressive-and-advanced-breast-cancers-finds-full-results-from-first-randomised-controlled-trial - "MIT researchers develop an AI model that can detect future lung cancer risk" | MIT | January 2023 | https://professional.mit.edu/news/articles/mit-researchers-develop-ai-model-can-detect-future-lung-cancer-risk - "GRAIL Reports Full Results From NHS-Galleri Trial at 2026 ASCO Annual Meeting" | GRAIL | May 30, 2026 | https://grail.com/press-releases/grail-reports-full-results-from-nhs-galleri-trial-demonstrating-substantial-reduction-in-stage-iv-cancer-diagnoses-at-2026-asco-annual-meeting/ AI DISCOVERING NEW CANCER BIOLOGY: - "AI reveals new class of cellular 'off switch' linked to cancer pathways" | Cornell University | September 9, 2026 | https://news.cornell.edu/stories/2026/09/ai-reveals-new-class-cellular-switch-linked-cancer-pathways - "Google launches AI co-scientist system" | Pharmaceutical Technology | February 20, 2025 | https://www.pharmtech.com/view/google-launches-ai-co-scientist-system - "A pathology foundation model for cancer diagnosis and prognosis prediction" | Nature | October 2024 | https://www.nature.com/articles/s41586-024-07894-z PERSONALIZED CANCER VACCINES: - "Merck and Moderna Announce Phase 3 INTerpath-001 Trial Met Endpoints of Recurrence-Free Survival" | Merck | August 19, 2026 | https://www.merck.com/news/merck-and-moderna-announce-phase-3-interpath-001-trial-of-intismeran-autogene-plus-keytruda-met-endpoints-of-recurrence-free-survival-rfs-and-distant-metastasis-free-survival-dmfs-in-patient/ - "mRNA-4157 Plus Pembrolizumab Continues to Improve RFS in High-Risk Melanoma" | Targeted Oncology | June 2024 | https://www.targetedonc.com/view/mrna-4157-plus-pembrolizumab-continues-to-improve-rfs-in-high-risk-melanoma THE CANCER LANDSCAPE: - "Global cancer statistics 2024: GLOBOCAN estimates for 34 cancers in 186 countries" | IARC / CA: A Cancer Journal for Clinicians | July 8, 2026 | https://www.iarc.who.int/news-events/global-cancer-statistics-2024-globocan-estimates-of-incidence-and-mortality-worldwide-for-34-cancers-in-186-countries/ - "National Cancer Act of 1971" | National Cancer Institute | December 23, 1971 | https://www.cancer.gov/about-nci/legislative/history/national-cancer-act-1971 - "Pancreatic Cancer Survival Rates by Stage" | American Cancer Society | SEER 2015-2021 data | https://www.cancer.org/cancer/pancreatic-cancer/detection-diagnosis-staging/survival-rates